318 related articles for article (PubMed ID: 10773013)
21. The acute effects of zolpidem, administered alone and with alcohol, on cognitive and psychomotor function.
Wilkinson CJ
J Clin Psychiatry; 1995 Jul; 56(7):309-18. PubMed ID: 7615484
[TBL] [Abstract][Full Text] [Related]
22. Distinguishing a benzodiazepine agonist (triazolam) from a nonagonist anxiolytic (buspirone) by electroencephalography: kinetic-dynamic studies.
Greenblatt DJ; Harmatz JS; Gouthro TA; Locke J; Shader RI
Clin Pharmacol Ther; 1994 Jul; 56(1):100-11. PubMed ID: 8033487
[TBL] [Abstract][Full Text] [Related]
23. Differential impairment of triazolam and zolpidem clearance by ritonavir.
Greenblatt DJ; von Moltke LL; Harmatz JS; Durol AL; Daily JP; Graf JA; Mertzanis P; Hoffman JL; Shader RI
J Acquir Immune Defic Syndr; 2000 Jun; 24(2):129-36. PubMed ID: 10935688
[TBL] [Abstract][Full Text] [Related]
24. Rifampin reduces plasma concentrations and effects of zolpidem.
Villikka K; Kivistö KT; Luurila H; Neuvonen PJ
Clin Pharmacol Ther; 1997 Dec; 62(6):629-34. PubMed ID: 9433391
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.
Troy SM; Lucki I; Unruh MA; Cevallos WH; Leister CA; Martin PT; Furlan PM; Mangano R
J Clin Psychopharmacol; 2000 Jun; 20(3):328-37. PubMed ID: 10831020
[TBL] [Abstract][Full Text] [Related]
26. Dynamics and kinetics of a modified-release formulation of zolpidem: comparison with immediate-release standard zolpidem and placebo.
Greenblatt DJ; Legangneux E; Harmatz JS; Weinling E; Freeman J; Rice K; Zammit GK
J Clin Pharmacol; 2006 Dec; 46(12):1469-80. PubMed ID: 17101746
[TBL] [Abstract][Full Text] [Related]
27. Sedative, memory, and performance effects of hypnotics.
Roehrs T; Merlotti L; Zorick F; Roth T
Psychopharmacology (Berl); 1994 Oct; 116(2):130-4. PubMed ID: 7862941
[TBL] [Abstract][Full Text] [Related]
28. Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal.
Griffiths RR; Sannerud CA; Ator NA; Brady JV
J Pharmacol Exp Ther; 1992 Mar; 260(3):1199-208. PubMed ID: 1312162
[TBL] [Abstract][Full Text] [Related]
29. Zolpidem, triazolam, and diazepam decrease distress vocalizations in mouse pups: differential antagonism by flumazenil and beta-Carboline-3-carboxylate-t-butyl ester (beta-CCt).
Rowlett JK; Tornatzky W; Cook JM; Ma C; Miczek KA
J Pharmacol Exp Ther; 2001 Apr; 297(1):247-53. PubMed ID: 11259551
[TBL] [Abstract][Full Text] [Related]
30. Triazolam and zolpidem: effects on human memory and attentional processes.
Mintzer MZ; Griffiths RR
Psychopharmacology (Berl); 1999 May; 144(1):8-19. PubMed ID: 10379619
[TBL] [Abstract][Full Text] [Related]
31. Zolpidem and triazolam interact differentially with a delay interval on a digit-enter-and-recall task.
Rush CR; Baker RW
Hum Psychopharmacol; 2001 Mar; 16(2):147-157. PubMed ID: 12404585
[TBL] [Abstract][Full Text] [Related]
32. Acute neurophysiological effects of the hypnotic zolpidem in healthy volunteers.
Lucchesi LM; Braga NI; Manzano GM; Pompéia S; Tufik S
Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):557-64. PubMed ID: 15866358
[TBL] [Abstract][Full Text] [Related]
33. Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers.
Hallam KT; Olver JS; McGrath C; Norman TR
Hum Psychopharmacol; 2003 Dec; 18(8):619-25. PubMed ID: 14696021
[TBL] [Abstract][Full Text] [Related]
34. Design and pharmacodynamic evaluation of novel dual release formulations of triazolam.
Smith RB; Kroboth PD; Folan MM; Kroboth FJ; Rosanske TW
Int J Clin Pharmacol Ther Toxicol; 1993 Sep; 31(9):422-9. PubMed ID: 8225690
[TBL] [Abstract][Full Text] [Related]
35. L-Dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers.
Andreu N; Chalé JJ; Senard JM; Thalamas C; Montastruc JL; Rascol O
Clin Neuropharmacol; 1999; 22(1):15-23. PubMed ID: 10047929
[TBL] [Abstract][Full Text] [Related]
36. Sensitivity to triazolam in the elderly.
Greenblatt DJ; Harmatz JS; Shapiro L; Engelhardt N; Gouthro TA; Shader RI
N Engl J Med; 1991 Jun; 324(24):1691-8. PubMed ID: 2034245
[TBL] [Abstract][Full Text] [Related]
37. Pharmocokinetics and pharmacodynamics of single-dose triazolam: electroencephalography compared with the Digit-Symbol Substitution Test.
Greenblatt DJ; Gan L; Harmatz JS; Shader RI
Br J Clin Pharmacol; 2005 Sep; 60(3):244-8. PubMed ID: 16120062
[TBL] [Abstract][Full Text] [Related]
38. Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans.
Rush CR; Baker RW; Wright K
Psychopharmacology (Berl); 1999 Jun; 144(3):220-33. PubMed ID: 10435388
[TBL] [Abstract][Full Text] [Related]
39. Effects of triazolam at three phases of the menstrual cycle.
Rukstalis M; de Wit H
J Clin Psychopharmacol; 1999 Oct; 19(5):450-8. PubMed ID: 10505587
[TBL] [Abstract][Full Text] [Related]
40. A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety.
Bailey JE; Papadopoulos A; Seddon K; Nutt DJ
J Psychopharmacol; 2009 Mar; 23(2):117-22. PubMed ID: 18562427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
